Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S A Rosenberg

Showing results (1-10 of 821) with videos related to

Pageof 83
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1986
MOPP after two decadesS A Rosenberg
The New England Journal of Medicine|October 25, 1979
Current concepts in cancer: non-Hodgkin's lymphoma--selection of treatment on the basis of histologic typeS A Rosenberg
Important Advances in Oncology|January 1, 1986
Adoptive immunotherapy of cancer using lymphokine activated killer cells and recombinant interleukin-2S A Rosenberg
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1988
Exploratory laparotomy and splenectomy for Hodgkin's disease: a commentaryS A Rosenberg
Important Advances in Oncology|January 1, 1992
Gene therapy of cancerS A Rosenberg
The Cancer Journal From Scientific American|February 11, 1998
Keynote address: perspectives on the use of interleukin-2 in cancer treatmentS A Rosenberg
Journal of the National Cancer Institute|May 1, 1977
Lysis of human normal and sarcoma cells in tissue culture by normal human serum: implications for experiments in human tumor immunologyS A Rosenberg
The New England Journal of Medicine|February 8, 1996
Secrecy in medical researchS A Rosenberg
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Reducing the toxicity of the combined modality therapy of favourable stage Hodgkin's diseaseS A Rosenberg
The Cancer Journal From Scientific American|July 1, 1995
The development of new cancer therapies based on the molecular identification of cancer regression antigensS A Rosenberg
Pageof 83

Showing results (1-10 of 821) with videos related to

Sort By:
Pageof 83
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1986
MOPP after two decadesS A Rosenberg
The New England Journal of Medicine|October 25, 1979
Current concepts in cancer: non-Hodgkin's lymphoma--selection of treatment on the basis of histologic typeS A Rosenberg
Important Advances in Oncology|January 1, 1986
Adoptive immunotherapy of cancer using lymphokine activated killer cells and recombinant interleukin-2S A Rosenberg
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1988
Exploratory laparotomy and splenectomy for Hodgkin's disease: a commentaryS A Rosenberg
Important Advances in Oncology|January 1, 1992
Gene therapy of cancerS A Rosenberg
The Cancer Journal From Scientific American|February 11, 1998
Keynote address: perspectives on the use of interleukin-2 in cancer treatmentS A Rosenberg
Journal of the National Cancer Institute|May 1, 1977
Lysis of human normal and sarcoma cells in tissue culture by normal human serum: implications for experiments in human tumor immunologyS A Rosenberg
The New England Journal of Medicine|February 8, 1996
Secrecy in medical researchS A Rosenberg
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Reducing the toxicity of the combined modality therapy of favourable stage Hodgkin's diseaseS A Rosenberg
The Cancer Journal From Scientific American|July 1, 1995
The development of new cancer therapies based on the molecular identification of cancer regression antigensS A Rosenberg
Pageof 83